Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Isagro is an Italian life sciences company that specializes in the research, development, and production of agrochemicals and biostimulants for global crop protection. Founded in 1992 and headquartered in Milan, the company is recognized for its proprietary discovery of active ingredients such as the fungicide Tetraconazole and the SDHI fungicide Fluindapyr. Isagro's business model integrates chemical synthesis with a growing focus on "biosolutions," including pheromones and microbial-based products designed for sustainable agriculture. In 2021, the company was acquired by the Gowan Company, a US-based family-owned agricultural solutions provider, leading to its delisting from the Borsa Italiana. Today, Isagro serves as a strategic hub for Gowan, leveraging its extensive manufacturing facilities in Italy and its R&D center in Novara to serve international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Isagro.